Trial Studying Chemotherapy in Nigerian Women With Triple Negative Breast Cancer
Conditions: Triple Negative Breast Cancer Interventions: Drug: Cyclophosphamide; Drug: Epirubicin; Drug: Docetaxel; Drug: Carboplatin; Procedure: Breast Surgery; Drug: Capecitabine Sponsors: University of Chicago Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Breast Cancer | Breast Surgery | Cancer | Cancer & Oncology | Chemotherapy | Docetaxel | Nigeria Health | Research | Taxotere | Women | Xeloda